BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32536208)

  • 21. Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.
    Conzelmann C; Müller JA; Perkhofer L; Sparrer KM; Zelikin AN; Münch J; Kleger A
    Clin Med (Lond); 2020 Nov; 20(6):e218-e221. PubMed ID: 32863274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cationic drugs and COVID-19.
    Brenna OV; Torretta S; Pignataro L; Di Berardino F
    Int J Immunopathol Pharmacol; 2020; 34():2058738420966078. PubMed ID: 33045858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
    Ayaz S; Crea F
    Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
    [No Abstract]   [Full Text] [Related]  

  • 25. How to Discover Antiviral Drugs Quickly.
    Parks JM; Smith JC
    N Engl J Med; 2020 Jun; 382(23):2261-2264. PubMed ID: 32433861
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential Unconventional Medicines for the Treatment of SARS-CoV-2.
    Coppola M; Mondola R
    Drug Res (Stuttg); 2020 Jun; 70(6):286. PubMed ID: 32428941
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?
    Thangaraju P; Gurunthalingam MP; Venkatesan S; Thangaraju E
    J Infect Public Health; 2020 Jun; 13(6):899-900. PubMed ID: 32451256
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
    Marmor MF
    Am J Ophthalmol; 2020 May; 213():A3-A4. PubMed ID: 32247518
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19: Stay Cool toward Corticosteroids.
    Fujishima S
    Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
    [No Abstract]   [Full Text] [Related]  

  • 30. Chloroquine for Covid 19: introducing drug repurposing to medical students.
    Koren G; Korn L
    Int J Med Educ; 2020 Jul; 11():155-157. PubMed ID: 32712597
    [No Abstract]   [Full Text] [Related]  

  • 31. Pre- and post-treatment chest CT changes in a patient with COVID-19.
    Fu B; Qian K; Fu X
    Med Clin (Barc); 2020 Jul; 155(1):49. PubMed ID: 32417029
    [No Abstract]   [Full Text] [Related]  

  • 32. Kidney Transplantation and COVID-19.
    Merhi B; Gohh R
    R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010
    [No Abstract]   [Full Text] [Related]  

  • 33. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
    Madhusoodanan J
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
    [No Abstract]   [Full Text] [Related]  

  • 34. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Carradori S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
    Martin JH; Bowden NA
    Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
    [No Abstract]   [Full Text] [Related]  

  • 36. Lessons from the Italian COVID-19 frontline.
    Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
    Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
    Jeon S; Ko M; Lee J; Choi I; Byun SY; Park S; Shum D; Kim S
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatments in the COVID-19 pandemic: an update on clinical trials.
    Tao Y; Tang LV; Hu Y
    Expert Opin Emerg Drugs; 2020 Jun; 25(2):81-88. PubMed ID: 32447996
    [No Abstract]   [Full Text] [Related]  

  • 39. Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?
    Maguire C; Frohman T; Zamvil SS; Frohman E; Melamed E
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32527763
    [No Abstract]   [Full Text] [Related]  

  • 40. Remote digital monitoring in clinical trials in the time of COVID-19.
    Goldsack JC; Izmailova ES; Menetski JP; Hoffmann SC; Groenen PMA; Wagner JA
    Nat Rev Drug Discov; 2020 Jun; 19(6):378-379. PubMed ID: 32409759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.